Liver regeneration is an angiogenesis-associated phenomenon

Annals of Surgery

Volumn 236, Issue 6, 2002, Pages 703-712

  Drixler, Tom A ^a   Vogten, Mathys J ^a   Ritchie, Ewan D ^a   Van Vroonhoven, Theo J M V ^b   Gebbink, Martijn F B G ^a   Voest, Emile E ^a   Borel Rinkes, Inne H M ^a   Neuhaus, P ^c   Drixler, T ^c   Clavien, P A ^c   Broelsch, C E ^c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b EEMLAND HOSPITAL   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALANINE AMINOTRANSFERASE; AMINOPHENOL; ANGIOSTATIN; ANILINE DERIVATIVE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CD31 ANTIGEN; LACTATE DEHYDROGENASE; LIVER ENZYME;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DETOXIFICATION; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER NECROSIS; LIVER REGENERATION; LIVER WEIGHT; MOUSE; NICK END LABELING; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; STAINING; TISSUE REPAIR; TUMOR GROWTH;

ANALYSIS OF VARIANCE; ANGIOGENESIS INHIBITORS; ANGIOSTATINS; ANIMALS; APOPTOSIS; CELL DIVISION; DISEASE MODELS, ANIMAL; HEPATECTOMY; HEPATOCYTES; LIVER; LIVER REGENERATION; MALE; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE FRAGMENTS; PLASMINOGEN; PROBABILITY; RANDOM ALLOCATION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 0036895249     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200212000-00002     Document Type: Article

References (45)

1. Folkman J. The role of aniogenesis in tumor growth. Semin Cancer Biol 1992; 3:65-71
2. Kerbel RS. Clinical trials of antiangiogenic drugs: Opportunities, problems, and assessment of initial results. J Clin Oncol 2001; 19:45S-51S.
3. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1:27-31.
4. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995; 1:149-153.
5. Dvorak HF, Nagy JA, Berse B, et al. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation., Ann NY Acad Sci 1992;667:101-111.
6. Polverini PH, Schmizu K, Solt DB. Genetic control of expression of the angiogenic phenotype. Northwest Dent Res 1989; 1:4-7.
7. Dvorak HF. Tumors: Wounds that do not heal. Similarity between tumor stroma generation and wound healing. N Engl J Med 1986; 315:1650-1658.
8. Hobson B, Denekamp J. Endothelial proliferation in tumours and normal tissues: Continuous labelling studies. Br J Cancer 1984; 49:405-413.
9. Reynolds LP, Killilea SD, Redmer DA. Angiogenesis in the female reproductive system. FASEB J 1992; 6:886-892.
10. Brown LF, Yeo KT, Berse B, et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992; 176:1375-1379.
11. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276:60-66.
12. Stolz DB, Mars WM, Petersen BE, et al. Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat. Cancer Res 1999; 59:3954-3960.
13. Fausto N, Laird AD, Webber EM. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J 1995; 9:1527-1536.
14. Mars WM, Liu ML, Kitson RP, et al. Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration. Hepatology 1995; 21:1695-1701.
15. Taniguchi E, Sakisaka S, Matsuo K, et al. Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem 2001; 49:121-130.
16. Sato T, El Assal ON, Ono T, et al. Sinusoidal endothelial cell proliferation and expression of angiopoietin/Tie family in regenerating rat liver. J Hepatol 2001; 34:690-698.
17. Shimizu H, Miyazaki M, Wakabayashi Y, et al. Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol 2001; 34:683-689.
18. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246:1306-1309.
19. Mochida S, Ishikawa K, Toshima K, et al. The mechanisms of hepatic sinusoidal endothelial cell regeneration: A possible communication system associated with vascular endothelial growth factor in liver cells. J Gastroenterol Hepatol 1998; 13(Suppl):S1-5.
20. Tomiya T, Tani M, Yamada S, et al. Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients. Gastroenterology 1992; 103:1621-1624.
21. Lindroos PM, Zarnegar R, Michalopoulos GK. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology 1991; 13:743-750.
22. Aoki M, Morishita R, Taniyama Y, et al. Therapeutic angiogenesis induced by hepatocyte growth factor: Potential gene therapy for ischemic diseases. J Atheroscler Thromb 2000; 7:71-76.
23. Aoki M, Morishita R, Taniyama Y, et al. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: Up-regulation of essential transcription factor for angiogenesis, etc. Gene Ther 2000; 7:417-427.
24. Drixler TA, Rinkes IH, Ritchie ED, et al. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. Cancer Res 2000; 60:1761-1765.
25. O'Reilly MS, Holmgren L, Chen C, et al. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996; 2:689-692.
26. Drixler TA, Rinkes IH, Ritchie ED, et al. Angiostatin inhibits pathological but not physiological retinal angiogenesis. Invest Ophthalmol Vis Sci 2001; 42:3325-3330.
27. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79:315-328.
28. Higgins GM, Anderson RM. Experimental pathology of the liver. Arch Pathol 1931;187-202.
29. Van de Kant HJG, Van Pelt AMM, Vergouwen RPFA, et al. A rapid immunogold-silver staining for detection of bromodeoxyuridine in large number of plastic sections, using microwave irradiation. Histochem J 1990; 22:321-326.
30. Vecchi A, Garlanda C, Lampugnani MG, et al. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur J Cell Biol 1994; 63:247-254.
31. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976; 13:29-83.
32. Evelo CT, Versteegh JF, Blaauboer BJ. Kinetics of the formation and secretion of the aniline metabolite 4-aminophenol and its conjugates by isolated rat hepatocytes. Xenobiotica 1984; 14:409-416.
33. Boot JH, Van Holsteijn CW, Seinen W, et al. Effects of sulphydryl reagents on the formation of the aniline metabolite 4-aminophenol and its sulphate and glucuronide conjugates in primary cultures of rat hepatocytes. Xenobiotica 1989; 19:1267-1273.
34. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63.
35. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407:249-257.
36. Pediaditakis P, Lopez-Talavera JC, Petersen B, et al. The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology 2001; 34:688-693.
37. Tanaka H, Taniguchi H, Mugitani T, et al. Angiogenesis inhibitor TNP-470 prevents implanted liver metastases after partial hepatectomy in an experimental model without impairing wound healing. Br J Surg 1996; 83:1444-1447.
38. Fausto N. Liver regeneration: from laboratory to clinic. Liver Transplant 2001; 7:835-844.
39. Wack KE, Ross MA, Zegarra V, et al. Sinusoidal ultrastructure evaluated during the revascularization of regenerating rat liver. Hepatology 2001; 33:363-378.
40. Stack MS, Gately S, Bafetti LM, et al. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation. Biochem J 1999; 340:77-84.
41. Moser TL, Stack MS, Asplin I, et al. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA 1999; 96:2811-2816.
42. Lucas R, Holmgren L, Garcia I, et al. Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood 1998; 92:4730-4741.
43. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
44. Fox SB, Leek RD, Weekes MP, et al. Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 1995; 177:275-200083.
45. Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997; 390:404-407.